Not worried because if they are able to get to a point where they need additional funding for say Phase II trials, I believe the interest here will be strong enough to chew through the dilutive shares.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.